Jonathan Chang analyst

Currently out of the existing stock ratings of Jonathan Chang, 110 are a BUY (67.9%), 52 are a HOLD (32.1%).

Jonathan Chang

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Chang, has had 51.71% of price targets met with an average potential upside of 31.38%, reached in 214 days on average.

Jonathan Chang has documented 302 price targets and ratings displayed on 24 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on REPL, at 03-Aug-2026.

Wall Street Analyst Jonathan Chang

Analyst best performing recommendations are on IMGN.
The best stock recommendation documented was for RVMD on 4/13/2026. The price target of $147 was fulfilled within 1 day with a profit of $10.7 (7.85%), with a performance score of 78.5.

Average potential price target upside

ADAP CALA IMGN IMTX KPTI MGNX ZLAB Zai Lab Ltd BCYC GMAB HARP KURA REPL RVMD ATNX RUBY TCRR VINC MRSN XNCR ARQL CAL NBTX NVCR TC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

$1

$4

3 years 3 months 8 days ago
(10-Aug-2023)

3/4 (75%)

$0.18 (21.95%)

245

Buy

$5

3 years 10 months 15 days ago
(03-Jan-2023)

0/2 (0%)

$3.33 (199.40%)

Buy

$9

$9

4 years 9 days ago
(09-Nov-2022)

2/3 (66.67%)

$1.29 (98.13%)

340

Hold

$3

4 years 6 months 9 days ago
(09-May-2022)

1/5 (20%)

$1.46 (94.81%)

377

Buy

$6

$16

7 years 6 months 11 days ago
(07-May-2019)

1/3 (33.33%)

$6.36 (92.59%)

388

Show more analysts

Please expand the browser size to see the chart

Which stock is Jonathan Chang most bullish on?

Potential upside of $15.34 has been obtained for NBTX

Which stock is Jonathan Chang most reserved on?

Potential downside of -$4.41 has been obtained for REPL
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?